Indian stocks poised to extend rebound ahead of RBI policy verdict
Indian shares are likely to open higher on Tuesday, extending their rebound from the previous session as supportive global cues and positive quarterly business updates lift sentiment ahead of a crucial central bank policy decision. GIFT Nifty futures were trading at 22,648 points, signalling a positive start for the benchmark Nifty 50.
Indian shares are seen opening higher on Tuesday, extending a rebound from the previous session as supportive global cues and quarterly business updates lifted sentiment ahead of a central bank policy decision. m. 75 on Monday. 7%, respectively, in the prior session, after recovering from their longest weekly losing streak in 25 years.
S. monetary tightening after softer-than-expected jobs data supported the move, while select financial firms' quarterly updates also helped. Consumer and energy shares gained as well. "Benchmark Nifty has shown signs of relief recovery after testing the crucial long-term support zone around 22,400-22,600.
Going ahead, the 22,650-22800 zone is likely to act as the immediate hurdle," said Ajit Mishra, senior vice president of research at Religare Broking. Attention will now shift to the Reserve Bank of India's interest rate decision on 6. Market consensus has shifted to a 25-basis-point rate hike, which would be the RBI's first increase since February 2023, as worries build over crude prices above $100 a barrel, a weaker rupee and the weakest monsoon in a decade. Asian equities opened firmer after Wall Street's overnight advance, with the Nasdaq Composite hitting a record high.
Brent crude futures were near $100 a barrel after dropping $2 on Monday. Higher Middle East oil exports and a Group of Seven pledge to lift supplies pressured prices, though disruption risks from the US-Iran war limited the decline. 99 billion rupees ($488 million). 82 billion rupees, according to provisional NSE data.
7% as of September 30, 2026, in its business update. 7% year-on-year as of September 30. Trent said standalone revenue from operations in the Godrej Consumer Products said its September quarter rose 23% year on year. The company also said it expects second-quarter consolidated revenue to increase in the high-teens.
Metropolis Healthcare said September-quarter revenue climbed 15% year on year, helped by double-digit growth in patient and test volumes. 2900 Indian rupees. Reporting by Bharath Rajeswaran in Bengaluru; editing by Sherry Jacob-Phillips. +91 9769003463.